Gilead Sciences (GILD) Receivables - Other (2019 - 2021)
Gilead Sciences' (GILD) quarterly Receivables - Other came in at $9.0 million in Q1 2021, down 85.0% YoY from $60.0 million in Q1 2020, and little changed on a QoQ basis from $9.0 million in Q4 2020.
Gilead Sciences (GILD) Receivables - Other (2019 - 2021) Analysis & Trends
Gilead Sciences (GILD) has 3 years of Receivables - Other data on file, last reported at $9.0 million in Q1 2021.
- Quarterly Receivables - Other fell 85.0% year-over-year to $9.0 million in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $9.0 million (down 85.0% YoY) and the FY2020 annual result came in at $9.0 million, down 75.68% from the prior year.
- Receivables - Other was little changed at $9.0 million in Q1 2021, from $9.0 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $60.0 million in Q1 2020 to a low of $9.0 million in Q4 2020.
- A 3-year average of $36.7 million and a median of $43.0 million in 2019 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2020 — Receivables - Other slumped 75.68% — and 2021, when it tumbled 85.0%.
- Tracing GILD's Receivables - Other over 3 years: stood at $37.0 million in 2019, then tumbled by 75.68% to $9.0 million in 2020, then changed by 0.0% to $9.0 million in 2021.
- The last three Receivables - Other figures came in at $9.0 million (Q1 2021), $9.0 million (Q4 2020), and $49.0 million (Q3 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 9.00 Mn |
| Mar 31, 2021 | 9.00 Mn |
| Dec 31, 2020 | 9.00 Mn |
| Dec 31, 2020 | 9.00 Mn |
| Sep 30, 2020 | 49.00 Mn |
| Sep 30, 2020 | 49.00 Mn |
| Jun 30, 2020 | 56.00 Mn |
| Jun 30, 2020 | 56.00 Mn |
| Mar 31, 2020 | 60.00 Mn |
| Mar 31, 2020 | 60.00 Mn |
| Dec 31, 2019 | 37.00 Mn |
| Dec 31, 2019 | 37.00 Mn |